my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
19-02-2007: ChemDiv, Inc. announced that Merck KGaA has renewed and expanded on an agreement with ChemDiv as its preferred provider of discovery libraries of lead-like small molecules through 2009. The new agreement expands the collaboration that has been going on for the last three years, and roughly doubles the FTE effort at ChemDiv's Chemical Diversity Research Institute in Moscow.
Under the terms of the agreement, a steering committee with representatives from Merck KGaA and ChemDiv will determine projects to be produced by ChemDiv for early stage discovery at Merck. Promising hits will then be further optimized and placed into Merck's discovery pipeline. Financial terms were not disclosed.
Watchlist
This is where you can add this news to your personal favourites
Merck wants to achieve 2014 goals already this year following a successful start
“Merck got off to a solid and profitable start in 2013 with all four divisions contributing to our organic sales growth. In addition, we are making excellent progress on our ‘Fit for 2018’ program. This can clearly be seen in the 19% increase in EBITDA pre one-time items,” said Karl-Ludwig ... more
International consortium develops dye-sensitized solar cells
Merck announced the start of a project sponsored by the German Federal Ministry of Education and Research (BMBF) to develop high-efficiency cobalt-based dye-sensitized solar cells (DSSCs). The project COBRA (organic cobalt-based low-cost printable large-area photovoltaics) will run for thre ... more
Merck’s Good Performance Continues In Third Quater 2012 During Transformation
“Even in these tough economic times and while in the midst of our own business transformation, Merck is performing well operationally,” said Karl-Ludwig Kley, Chairman of the Executive Board of Merck. “We are especially pleased with the excellent results from our Merck Serono and Performanc ... more
New SeQuant® ZIC®-cHILIC HPLC columns from Merck Millipore
SeQuant® ZIC®-cHILIC: a revolutionary HPLC column specially designed for the separation of polar hydrophilic compounds. more
SeQuant® ZIC®-HILIC columns make analysis of complex food samples easier
If samples have to be analyzed for contamination with pesticides, fungicides or antibiotics, Merck Millipore offers special HPLC columns and tips more
Innovative Point-of-Use Water Purification Provided by Millipore's New Milli-Q® Integral System
The Milli-Q® Integral water purification system provides you with integrated, reliable lab-scale production of pure and ultrapure water more
Merck Millipore Introduces Unique Lab Water E-Solution: Millitrack® Compliance
This unique fully-embedded water purification system software has been developed especially for the pharmaceutical, biotech and contract labs more
The Lab Solutions business unit of Merck Millipore supplies products for research, analytical and clinical laboratories in a wide variety of industries. We are one of the leading suppliers of laboratory chemicals, lab water equipment and consumables. For inorganic chemistry, we offer reagen ... more
Millipore is a life science leader providing cutting edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the worlds challenging human health issues. From research to development ... more
Merck Schuchardt OHG, a 100% subsidiary of Merck KGaA, Germany, has, for the last 135 years, been one of the leading German producers and suppliers of organic intermediates, fine chemicals, reagents and solvents for laboratories, medium-sized and bulk production. more
ChemDiv and Achaogen Enter Into a Discovery Collaboration
ChemDiv, Inc. has announced that it has entered into a discovery collaboration with Achaogen, Inc. Applying its expertise in medicinal and synthetic chemistry, ChemDiv will support Achaogen in identifying and developing novel antibacterial compounds. Financial terms of the collaboration wer ... more
Kaken Pharmaceutical Co., Ltd. and ChemDiv, Inc. partner in Drug Discovery Deal
ChemDiv, Inc. and Kaken Pharmaceutical Co., Ltd. of Tokyo, Japan have announced that they entered into a joint Drug Discovery collaboration involving undisclosed therapeutic targets. ChemDiv is to produce lead candidates employing its Discovery Outsource TM platform, including proprietary ... more
ChemDiv, Inc. announced that Merck KGaA has renewed and expanded on an agreement with ChemDiv as its preferred provider of discovery libraries of lead-like small molecules through 2009. The new agreement expands the collaboration that has been going on for the last three years, and roughly ... more
ChemDiv Inc. (ChemDiv) is a global chemistry-driven contract research organization focused on scientific innovation to deliver services that meet the drug discovery needs of its partners. Drawing on a long heritage in small-molecule chemistry research, a dedicated and personal approach to ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
